Clinical Trial Update: Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether adjusting chemotherapy dose and the SALVage weekly dose-dense regimen improves outcomes in patients with poor-prognosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Ovarian Cancer | Phase 3 | Status: RECRUITING